• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CytomX Therapeutics, Inc. - Common Stock (NQ:CTMX)

4.250 -0.010 (-0.23%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,810,911
Open 4.270
Bid (Size) 4.260 (400)
Ask (Size) 4.270 (900)
Prev. Close 4.260
Today's Range 4.210 - 4.660
52wk Range 0.4000 - 4.660
Shares Outstanding 66,767,779
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
CytomX Therapeutics Inc (NASDAQ:CTMX) Reports Q3 2025 Earnings Miss, Stock Falls ↗
November 06, 2025
CytomX Therapeutics Q3 2025 earnings miss analyst estimates for revenue and EPS, triggering a negative market reaction. 
Via Chartmill
Topics Earnings
News headline image
Earnings Scheduled For November 6, 2025 ↗
November 06, 2025
 
Via Benzinga

Performance

YTD
N/A
N/A
1 Month
+4.2%
+4.2%
3 Month
+29.6%
+29.6%
6 Month
+79.3%
+79.3%
1 Year
+276.1%
+276.1%

More News

Read More
News headline image
CytomX Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) ↗
October 21, 2025
Via Benzinga
News headline image
Why CytomX Therapeutics Stock Was Skyrocketing This Week ↗
September 26, 2025
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
September 25, 2025
Via Benzinga
News headline image
Earnings Scheduled For August 7, 2025 ↗
August 07, 2025
Via Benzinga
News headline image
What's going on in today's after hours session ↗
September 25, 2025
Via Chartmill
News headline image
Why Serina Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket ↗
August 26, 2025
Via Benzinga
News headline image
Intuit, Workday And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
August 22, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
August 12, 2025
Via Benzinga
News headline image
CytomX (CTMX) Q2 Revenue Drops 26% ↗
August 07, 2025
Via The Motley Fool
Topics Intellectual Property
News headline image
CytomX Therapeutics Inc (NASDAQ:CTMX) Reports Q2 2025 Revenue Beat and Break-Even EPS ↗
August 07, 2025
Via Chartmill
News headline image
This Lexeo Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday ↗
July 31, 2025
Via Benzinga
News headline image
Deep Dive Into CytomX Therapeutics Stock: Analyst Perspectives (4 Ratings) ↗
July 31, 2025
Via Benzinga
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers
July 09, 2025
Via Investor Brand Network
News headline image
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers
July 09, 2025
Via FinancialNewsMedia
Topics Death
News headline image
CYTOMX THERAPEUTICS INC (NASDAQ:CTMX) - A Strong Contender in High-Growth Biotech ↗
July 08, 2025
Via Chartmill
News headline image
Heico, Monro, Abercrombie & Fitch, Joby Aviation And Other Big Stocks Moving Higher On Wednesday ↗
May 28, 2025
Via Benzinga
News headline image
CytomX Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) ↗
May 20, 2025
Via Benzinga
News headline image
This CytomX Therapeutics Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday ↗
May 15, 2025
Via Benzinga
News headline image
CytomX Stock Hits 2-Month High After Upbeat Q1 Earnings, Promising Early Data For Cancer Drug ↗
May 12, 2025
Via Stocktwits
News headline image
Top movers analysis one hour before the close of the markets on 2025-05-12: top gainers and losers in today's session. ↗
May 12, 2025
Via Chartmill
News headline image
Monday's session: most active stocks ↗
May 12, 2025
Via Chartmill
News headline image
Stocks Under $1 to Watch: TAOP, WLGS, HIT, CTMX, JYD – Major Updates, Earnings & Offerings, More Inside….
May 12, 2025
Via AB Newswire
Topics Economy
News headline image
Which stocks are moving on Monday? ↗
May 12, 2025
Via Chartmill

Frequently Asked Questions

Is CytomX Therapeutics, Inc. - Common Stock publicly traded?
Yes, CytomX Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does CytomX Therapeutics, Inc. - Common Stock trade on?
CytomX Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for CytomX Therapeutics, Inc. - Common Stock?
The ticker symbol for CytomX Therapeutics, Inc. - Common Stock is CTMX on the Nasdaq Stock Market
What is the current price of CytomX Therapeutics, Inc. - Common Stock?
The current price of CytomX Therapeutics, Inc. - Common Stock is 4.250
When was CytomX Therapeutics, Inc. - Common Stock last traded?
The last trade of CytomX Therapeutics, Inc. - Common Stock was at 01/02/26 04:00 PM ET
What is the market capitalization of CytomX Therapeutics, Inc. - Common Stock?
The market capitalization of CytomX Therapeutics, Inc. - Common Stock is 283.76M
How many shares of CytomX Therapeutics, Inc. - Common Stock are outstanding?
CytomX Therapeutics, Inc. - Common Stock has 284M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap